Literature DB >> 10064671

The natural history of microalbuminuria in adolescents with type 1 diabetes.

D Gorman1, E Sochett, D Daneman.   

Abstract

OBJECTIVE: To describe the natural history of urinary albumin excretion measured initially during the first decade of type 1 diabetes in adolescents and to identify predictors of the onset and progression of microalbuminuria (MA) in this population. STUDY
DESIGN: A retrospective cohort follow-up study was done on 76 adolescents whose albumin excretion rate (AER) had been determined in the first decade of their diabetes. Subjects were monitored for a mean of 6 years after initial AER testing. Those with MA were compared with a group with similar age, sex, and diabetes duration who initially had normoalbuminuria (NA).
RESULTS: Of the 28 with initial MA, 9 (32%) regressed (8 to within the NA range), whereas MA was persistent in 10 (36%) and progressed in 9 (32%), 5 to overt proteinuria. Of the 47 who had initial NA, MA developed in 14 (30%) and overt proteinuria in 3 (6%). With MA status at follow-up as the dependent variable, multiple regression analysis showed that initial AER (P =.0002) and hemoglobin A1c (P =.02) measured at the same time were significant independent variables.
CONCLUSIONS: These data suggest that in adolescents: (1) MA detected in the first decade of disease will persist or progress in the second decade in approximately two thirds of patients, and new MA will develop in a third of those initially normoalbuminuric; and (2) the appearance, persistence, or progression of MA is influenced in large part by metabolic control assessed by hemoglobin A1c both at initial MA screening and throughout the course of diabetes. This underlines the need for MA screening starting early in the course of type 1 diabetes in adolescents and for maintenance of good metabolic control.

Entities:  

Mesh:

Year:  1999        PMID: 10064671     DOI: 10.1016/s0022-3476(99)70459-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Occurrence of microalbuminuria in young people with Type 1 diabetes: importance of age and diabetes duration.

Authors:  C R Alleyn; L K Volkening; J Wolfson; A Rodriguez-Ventura; J R Wood; L M B Laffel
Journal:  Diabet Med       Date:  2010-05       Impact factor: 4.359

2.  Children are not small adults.

Authors:  Heather Dean; Elizabeth Sellers; Patricia Birk; Tom Blydt-Hansen; Malcolm Ogborn
Journal:  CMAJ       Date:  2003-02-04       Impact factor: 8.262

Review 3.  Microvascular disease in children and adolescents with type 1 diabetes and obesity.

Authors:  M Loredana Marcovecchio; Francesco Chiarelli
Journal:  Pediatr Nephrol       Date:  2010-08-19       Impact factor: 3.714

4.  Predictive value of albuminuria in American Indian youth with or without type 2 diabetes.

Authors:  Nan Hee Kim; Meda E Pavkov; William C Knowler; Robert L Hanson; E Jennifer Weil; Jeffrey M Curtis; Peter H Bennett; Robert G Nelson
Journal:  Pediatrics       Date:  2010-03-01       Impact factor: 7.124

Review 5.  Clinical practice: proteinuria.

Authors:  Gema Ariceta
Journal:  Eur J Pediatr       Date:  2010-11-10       Impact factor: 3.183

6.  Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study.

Authors:  Rakesh Amin; Barry Widmer; A Toby Prevost; Phillip Schwarze; Jason Cooper; Julie Edge; Loredana Marcovecchio; Andrew Neil; R Neil Dalton; David B Dunger
Journal:  BMJ       Date:  2008-03-18

Review 7.  Long-term Outcomes in Youths with Diabetes Mellitus.

Authors:  Neil H White
Journal:  Pediatr Clin North Am       Date:  2015-05-23       Impact factor: 3.278

Review 8.  Diabetic nephropathy in children and adolescents.

Authors:  Radovan Bogdanović
Journal:  Pediatr Nephrol       Date:  2007-10-17       Impact factor: 3.714

Review 9.  Diabetes and chronic kidney disease: lessons from the Pima Indians.

Authors:  Kevin V Lemley
Journal:  Pediatr Nephrol       Date:  2008-03-05       Impact factor: 3.714

10.  Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT).

Authors: 
Journal:  BMC Pediatr       Date:  2009-12-17       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.